News

Published on 13 Oct 2023 on Zacks via Yahoo Finance

Scholar Rock (SRRK) Up on Pipeline Advancement, Stock Offering


Article preview image

Shares of clinical-stage biopharmaceutical company Scholar Rock Holding Corporation SRRK gained 17.7% after the company announced plans to expand into the cardiometabolic disorders space and pricing of its public offering.

The company will leverage its experience in myostatin inhibition to advance SRK-439, a novel investigational myostatin inhibitor for treating cardiometabolic disorders, with an initial focus on obesity. An investigational new drug application (IND) submission is targeted in 2025.

Preclinical data support advancing SRK-439 for the treatment of obesity. Studies in diet-induced obese mice showed that SRK-439, in combination with GLP-1 receptor agonist (GLP-1 RA), achieved a dose-dependent reversal of lean mass loss during GLP-1 RA-mediated weight loss and an increase in fat mass loss mediated by GLP-1 RA treatment.

NASDAQ.SRRK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Scholar Rock Holding Corporation (NASDAQ:SRRK) Ranks High On The List Of Worst...

We recently compiled a list of 10 Worst Falling Stocks To Buy Now. In this article, we will look ...

Insider Monkey · via Yahoo Finance 25 Sep 2024

Scholar Rock Holding Corporation (SRRK): This Small-Cap Healthcare Stock Is A...

We recently compiled a list of the 10 Best Small-Cap Healthcare Stocks To Buy Now. In this articl...

Insider Monkey · via Yahoo Finance 22 Aug 2024

Scholar Rock Holding Corporation (SRRK): The Most Shorted Stock Loved by...

We recently compiled a list of the 10 Most Shorted Stocks That Are Loved by Analysts. In this...

Insider Monkey · via Yahoo Finance 22 Jul 2024

Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2023 Earnings Call Transcript

Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2023 Earnings Call Transcript November 7, 2023 ...

Insider Monkey via Yahoo Finance 12 Nov 2023

Here's Why 'Trend' Investors Would Love Betting on Scholar Rock Holding Corporation (SRRK)

When it comes to short-term investing or trading, they say "the trend is your friend." And there'...

Zacks via Yahoo Finance 31 Oct 2023

All You Need to Know About Scholar Rock Holding Corporation (SRRK) Rating Upgrade to Strong Buy

Scholar Rock Holding Corporation (SRRK) appears an attractive pick, as it has been recently upgra...

Zacks via Yahoo Finance 24 Oct 2023

Wall Street Analysts Believe Scholar Rock Holding Corporation (SRRK) Could Rally...

The mean of analysts' price targets for Scholar Rock Holding Corporation (SRRK) points to a 264.5...

Zacks · via Yahoo Finance 23 Oct 2023

Over $15M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying - Asana...

Although U.S. stocks closed higher on Monday, there were a few notable insider trades. When insid...

Benzinga 17 Oct 2023

Institutional investors are Scholar Rock Holding Corporation's (NASDAQ:SRRK) biggest bettors and...

Key Insights Institutions' substantial holdings in Scholar Rock Holding implies that they have si...

Simply Wall St. via Yahoo Finance 15 Oct 2023

Scholar Rock (SRRK) Up on Pipeline Advancement, Stock Offering

Shares of clinical-stage biopharmaceutical company Scholar Rock Holding Corporation SRRK gained 1...

Zacks via Yahoo Finance 13 Oct 2023